CILIDIN TRIO 20MG TABLET is a combination of Chlorthalidone, Cilnidipine and Olmesartan which belongs to the group of medicines called Antihypertensive agents. It is used to treat essential hypertension.
Hypertension also known as high or raised blood pressure, is a condition in which the blood vessels have persistently raised pressure. Blood is carried from the heart to all parts of the body in the vessels. Each time the heart beats, it pumps blood into the vessels.
Blood pressure is created by the force of blood pushing against the walls of blood vessels (arteries) as it is pumped by the heart. The higher the pressure, the harder the heart has to pump.
During the course of treatment your doctor might regularly monitor your blood pressure, kidney function and electrolyte balance at regular intervals to avoid any untoward side effects.
CILIDIN TRIO 20MG TABLET is not recommended for use in patients with liver, kidney, and heart disease. Consult your doctor before taking.
CILIDIN TRIO 20MG TABLET is not recommended for use during pregnancy. It is not recommended for use in breastfeeding women as it may pass through the breastmilk to the baby. Consult your doctor for advice.
Safety and efficacy in pediatric patients is not established. Consult your doctor before taking. CILIDIN TRIO 20MG TABLET should be used with caution in elderly patients of 65 years and above. Consult your doctor for advice.
The most common side effects of taking CILIDIN TRIO 20MG TABLET are dizziness, nausea, headache, constipation, fever, chills. Consult your doctor if the above-mentioned side effects persists for a longer duration.
CILIDIN TRIO 20MG TABLET effectively reduces the blood pressure where Chlorthalidone acts by enhancing excretion of sodium (which is necessary for constriction of blood vessels) and water from the body causing the blood vessels to relax and Cilnidipine makes the blood vessels to relax and thus lowers the blood pressure by blocking the calcium entry in blood vessels which is necessary for the smooth muscle contraction. Olmesartan acts by blocking the effects of Angiotensin II (substance produced in your body which causes narrowing of blood vessels).
Take CILIDIN TRIO 20MG TABLET as advised by your physician. Swallow this medicine with a glass of water and do not crush or chew the medicine. Your doctor will decide the right dose and duration depending upon your age, body weight and disease condition.
Stop taking CILIDIN TRIO 20MG TABLET and contact your doctor immediately if you experience any of the following side effects:
Nausea or Vomiting:
Take this medicine with, or just after meals. Stick to simple meals. Avoid eating oil rich or spicy foods, sugary snacks, and drinks. Try to avoid drinking too much liquid along with your meals, drink slowly in between meals. Consult your doctor for advice.
Constipation:
Eat plenty of fibre rich foods such as fresh fruits, vegetables, and cereals and drink plenty of water. Exercise more regularly.
Dizziness
Lie, or sit down immediately when you feel dizzy. If you are feeling a severe episode of dizziness, lie in a dark and quite place with eyes closed. Discuss with your doctor.
Headache:
Apply hot or cold-water bag on your head. Try to take rest in a quiet and dark room. Drink tea or coffee. Massage the scalp or head with mild pressure. Consult your doctor for advice.
CILIDIN TRIO 20MG TABLET is not recommended for use in pregnant women. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
CILIDIN TRIO 20MG TABLET is not recommended for use in breastfeeding women as it may pass through the breastmilk to the baby. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
Do not drive or operate any machines if you feel dizzy or sleepy after taking CILIDIN TRIO 20MG TABLET. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
Avoid alcohol consumption as it may aggravate the side effects of CILIDIN TRIO 20MG TABLET.
CILIDIN TRIO 20MG TABLET is not recommended in patients with anuria (failure of the kidneys to produce urine). It should be used with caution in patients with severe renal disease. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
CILIDIN TRIO 20MG TABLET is not recommended for use in patients with liver failure and it should be used with caution in patients with mild to moderate liver disease. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
Do not take CILIDIN TRIO 20MG TABLET if you are allergic to Chlorthalidone, Cilnidipine and Olmesartan or any other ingredients of this medicine.
CILIDIN TRIO 20MG TABLET is not recommended for patients who had cardiogenic shock, myocardial infarction (heart attack), acute unstable angina, and aortic stenosis (blocked blood supply in heart). Consult your doctor for advice.
CILIDIN TRIO 20MG TABLET is not recommended for use if you:
Before taking CILIDIN TRIO 20MG TABLET, inform your doctor if you have:
Use in pediatrics:
Safety and efficacy in pediatric patients is not established. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
Use in geriatrics:
CILIDIN TRIO 20MG TABLET should be used with caution in elderly patients of 65 years and above. Before taking CILIDIN TRIO 20MG TABLET, consult your doctor.
A. Drug - Drug interactions:
Before taking CILIDIN TRIO 20MG TABLET inform your doctor if you are taking any of the following medicine:
B. Drug - Food interaction:
Avoid drinking grapefruit juice while taking CILIDIN TRIO 20MG TABLET as it may increase the levels of this medicine n body.
Overdosage:
If you or anyone else accidentally takes too much of CILIDIN TRIO 20MG TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage includes low blood pressure, dizziness, nausea, sleepiness, and electrolyte disturbances associated with cardiac arrhythmias (irregular heartbeat) and muscle stiffness.
Drug | : | Chlorthalidone, Cilnidipine, Olmesartan |
Pharmacological Category | : | Thiazide Diuretics, Calcium Channel Blockers, Angiotensin II receptor antagonist |
Therapeutic Indication | : | High blood pressure |
Dosage Forms | : | Tablet |
Q: What is CILIDIN TRIO 20MG TABLET used for?
A: CILIDIN TRIO 20MG TABLET is a combination of Chlorthalidone, Cilnidipine and Olmesartan. It is used in the treatment of essential hypertension in adults.
Q: Is CILIDIN TRIO 20MG TABLET safe in pregnant and breast-feeding women?
A: CILIDIN TRIO 20MG TABLET is not recommended for use in pregnant and breastfeeding women. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
Q: Is CILIDIN TRIO 20MG TABLET safe for elder patients?
A: CILIDIN TRIO 20MG TABLET should be used with caution in elder patients of 65 years and above. Your doctor will decide the correct dose and duration of the treatment with CILIDIN TRIO 20MG TABLET for you along with regular monitoring.
Q: Does CILIDIN TRIO 20MG TABLET can be taken by patients with kidney and liver disease?
A: CILIDIN TRIO 20MG TABLET is not recommended for use in patients with kidney and liver failure. It should be used with caution in patients having progressive liver disease. Consult your doctor before taking CILIDIN TRIO 20MG TABLET.
Q: Does CILIDIN TRIO 20MG TABLET cause dizziness?
A: Yes, it may cause dizziness in some individual. Lie, or sit down immediately when you feel dizzy. If you are feeling a severe episode of vertigo, lie in a dark and quite place with eyes closed. Talk to your doctor if the symptom does not improve.
1. KD. Tripathi. Diuretics, Drugs Affecting Renin Angiotensin SystemEssentials of medical pharmacology. Eighth edition. 2019. Page – 630-632, 536-538.
2. Connor C. Kerndt; Jayesh B. Patel. Chlorthalidone. National Library of Medicine, National center for biotechnology information. Revised in May 2022. [Accessed 17th May 2022] https://www.ncbi.nlm.nih.gov/books/NBK553174/
3. Paul Muntner, PhD, Emily B. Levitan, PhD, Amy I. Lynch, PhD, Lara M. Simpson, PhD, Jeffrey Whittle, MD, Barry R. Davis, MD, PhD, John B. Kostis, MD, Paul K. Whelton, MD, and Suzanne Oparil, MD . Effect of Chlorthalidone, Amlodipine, and Lisinopril on Visit-to-Visit Variability of Blood Pressure: Results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. National Library of Medicine, National center for biotechnology information. PubMed Central. Revised in May 2014. [Accessed 17th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141643/
4. J. B. CHEMICALS & PHARMACEUTICALS LTD. [Revised in November 2021] [Accessed 17th May 2022] https://jbpharma.com/wp-content/uploads/2021/11/CILACAR-C-12.5_PI_India_November-2021.pdf
5. Glenmark Pharmaceuticals Europe Limited. Electronic Medicines Compendium (EMC). [Revised in March 2022] [Accessed 17th May 2022] https://www.medicines.org.uk/emc/files/pil.9886.pdf
6. Micro labs Ltd. [Accessed 17th May 2022] http://www.microlabsltd.com/elibrary/node/1691
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.